Top Markets
Coin of the day
SeqLL Inc. SeqLL Inc.

SeqLL Inc.

SQL
Rang in Aktien #17411
Globally, SeqLL Inc. operates as a life sciences enterprise, providing... Globally, SeqLL Inc. operates as a life sciences enterprise, providing specialized instrumentation and research services. The company's primary focus involves the innovation, refinement, and production of cutting-edge genetic analysis technologies. Among its key offerings is the proprietary true single molecule sequencing (tSMS) platform, which facilitates the direct sequencing of DNA and RNA at the individual molecular level. SeqLL has established collaborative agreements with a range of esteemed organizations, including Bernstein Laboratory, Ting Laboratory, The Jackson Laboratory for Genomic Medicine, Weizmann Institute of Science, True Bearing Diagnostics, Inc., and Tetracore, Inc. Its diverse clientele encompasses academic institutions, governmental agencies, hospitals and medical centers, pharmaceutical and biotechnology companies, and various non-profit research groups. Established in 2013, the company maintains its headquarters in Billerica, Massachusetts.
Aktienkurs
$6.60
Zuletzt synchronisiert: 2025-02-06
Marktkapitalisierung
$242.77M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel SeqLL Inc. (SQL)

Kategorie

EPS für SeqLL Inc. (SQL)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von SeqLL Inc. beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von SeqLL Inc. von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
$18.62 -
US
$5.65 -
US
- -
CN
$-1.36 -
US
$8.13 -
US